Xiwei XU
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07371234) | Xiwei XU | 2025-12-15 |
Track Xiwei XU automatically
Every clearance here is in the API, with alerts when new ones post.